ABUS Archives

Arbutus Biopharma Corporation (NASDAQ: ABUS) and Antios Therapeutics Inc. Dose First...

admin - December 23, 2021 0

Arbutus Biopharma Corporation (NASDAQ: ABUS) Announces Interim Phase 1a/1b Clinical Study...

Gavins Felicity - December 14, 2021 0

CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics

Ward Sport - May 1, 2024 0

Investors and industry watchers are closely monitoring CytomX Therapeutics, Inc. (NASDAQ: CTMX), which has seen a significant uptick in its stock price...

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...

May 1, 2024

GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024

April 30, 2024

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...

April 18, 2024

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....

April 1, 2024

CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…

GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….

Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…

S&P 500 could move higher as per technical analysis (ARM, S&P)

Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)

Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)

BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…

Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…

Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…

Micro and Macro Tailwinds Converge for KULR

ISWH and the Rebirth of the Crypto Cycle

Tag: ABUS

Arbutus Biopharma Corporation (NASDAQ: ABUS) and Antios Therapeutics Inc. Dose First...

Arbutus Biopharma Corporation (NASDAQ: ABUS) Announces Interim Phase 1a/1b Clinical Study...

Recent Post

CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing...

GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....

CytomX Therapeutics (NASADAQ: CTMX) Revolutionizing Cancer Treatment with Groundbreaking Biologics

Cyclacel Pharmaceuticals (NASDAQ: CYCC) Sees Significant Stock Volatility Amid New Financing…

GeneDx Holdings Corp. (WGS) Bolsters Financial and Strategic Position in 2024

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….

Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…

S&P 500 could move higher as per technical analysis (ARM, S&P)

Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)

Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)

BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…

Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…

Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…

Micro and Macro Tailwinds Converge for KULR

ISWH and the Rebirth of the Crypto Cycle